Press Releases
Please click here if you wish to receive an e-mail notification regarding Alector press releases.
Nov 11, 2020
Nov 10, 2020
Alector Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Nov 02, 2020
Oct 22, 2020
Alector to Highlight Early-Stage Cancer Programs at Upcoming Scientific Forums
Sep 03, 2020
Aug 11, 2020
Alector Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Aug 04, 2020
Jul 28, 2020
Alector Announces Promising Preliminary Data from AL001 Phase 1b and Phase 2 Open-Label Long-Term Dosing Study of People with Frontotemporal Dementia
Jul 24, 2020
Alector Doses First Patient in Pivotal Phase 3 INFRONT-3 Trial Evaluating AL001 in Patients with Frontotemporal Dementia
Jul 21, 2020
Alector to Present Data from the AL001 Phase 2 Open-Label Study in Frontotemporal Dementia at the 2020 Alzheimer’s Association International Conference
Displaying 1 - 10 of 26